Table 1.
Characteristics of Study Participants
| N | Controls (n = 28) | Patients With ESRD-HD (n = 29) | p Value | |
|---|---|---|---|---|
|
| ||||
| Age, yrs | 57 | 46 ± 11 | 48 ± 10 | 0.51 |
| Sex, % male | 57 | 36 | 52 | 0.22 |
| Race, % white | 57 | 46 | 34 | 0.36 |
| Body mass index, kg/m2 | 57 | 31.2 ± 7.2 | 31.6 ± 7.9 | 0.66 |
| Diabetes mellitus, % | 57 | 50 | 48 | 0.90 |
| Cardiovascular disease, % | 57 | 39 | 34 | 0.71 |
| Statin usage, % | 57 | 29 | 31 | 0.84 |
| ACEI/ARB, % | 57 | 32 | 34 | 0.85 |
| hsCRP, mg/dl | 56 | 1.1 (0.6,5.1) | 6.2 (3.1,17.7) | 0.001 |
| Total cholesterol, mg/dl | 56 | 198 ± 66 | 170 ± 35 | 0.12 |
| Triglycerides, mg/dl | 56 | 95 (73,124) | 102 (75,135) | 0.84 |
| HDL, mg/dl | 56 | 40.6 ± 9.9 | 36.9 ± 17.2 | 0.08 |
| LDL, mg/dl | 56 | 139 ± 64 | 110 ± 31 | 0.24 |
Continuous variables are presented as mean ± standard deviation or median with interquartile range. Categorical variables are presented as percentages. The Wilcoxon rank sum test was used for comparing continuous variables, and categorical variables were compared using the chi-square test.
ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; ESRD-HD = end-stage renal disease on chronic hemodialysis; HDL = high-density lipoprotein; hsCRP = high-sensitivity C-reactive protein; LDL = low-density lipoprotein.